Unicycive Therapeutics Q4 EPS $(0.35) Misses $(0.17) Estimate
Unicycive Therapeutics Q4 EPS $(0.35) Misses $(0.17) Estimate
Unicycive Therapeutics第四季度每股收益美元（0.35美元）未达到预期（0.17美元）
Unicycive Therapeutics (NASDAQ:UNCY) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.17) by 105.88 percent. This is a 31.37 percent increase over losses of $(0.51) per share from the same period last year.
Unicycive Therapeutics（纳斯达克股票代码：UNCY）公布的季度亏损为每股0.35美元，比分析师普遍预期的0.17美元（0.17美元）低105.88％。与去年同期每股亏损0.51美元（0.51美元）相比，增长了31.37％。